CKD Bio Corp
KRX:063160

Watchlist Manager
CKD Bio Corp Logo
CKD Bio Corp
KRX:063160
Watchlist
Price: 21 250 KRW 0.47% Market Closed
Market Cap: ₩116.7B

Operating Margin

2.5%
Current
Improving
by 6.6%
vs 3-y average of -4.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
2.5%
=
Operating Income
₩3.7B
/
Revenue
₩149.3B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
2.5%
=
Operating Income
₩3.7B
/
Revenue
₩149.3B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
CKD Bio Corp
KRX:063160
116.6B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
529.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
222B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
FR
Sanofi SA
PAR:SAN
96.9B EUR
Loading...

Market Distribution

In line with most companies in Korea
Percentile
48th
Based on 2 615 companies
48th percentile
2.5%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

CKD Bio Corp
Glance View

Market Cap
116.7B KRW
Industry
Pharmaceuticals

CKD Bio Corp. engages in the development and manufacture of active pharmaceutical ingredients. The company is headquartered in Seoul, Seoul. The company went IPO on 2001-12-11. The firm mainly provides antibiotic ingredients, consisting of demethylchlortetracyclines (DMCTs) and rifampicins. The company also provides immunosuppressive agents, including cyclosporin and tacrolimus; remedies for diabetes, such as acarbose, and potassium clavulanate used for beta-lactam inhibitors. The firm distributes its products within domestic market and to overseas markets, such as America, China, Europe, Africa, Southeast Asia, Latin America and the Middle East.

Intrinsic Value
23 091.05 KRW
Undervaluation 8%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
2.5%
=
Operating Income
₩3.7B
/
Revenue
₩149.3B
What is CKD Bio Corp's current Operating Margin?

The current Operating Margin for CKD Bio Corp is 2.5%, which is above its 3-year median of -4.1%.

How has Operating Margin changed over time?

Over the last 3 years, CKD Bio Corp’s Operating Margin has increased from -5.8% to 2.5%. During this period, it reached a low of -15.7% on Sep 30, 2023 and a high of 6.4% on Dec 31, 2024.

Back to Top